Logo Image
News
All News
Publications
All PublicationsPharmTechPharmTech Europe
Multimedia
All VideosAsk the ExpertBehind The HeadlinesDrug Digest VideosDrug Solutions PodcastShorts
Conferences
Conference CoverageConference Listing
More
Webcasts
Resources
ICH Q9 Revision: A Comprehensive Resource on Quality Risk ManagementPartnersPeer-Reviewed ResearchPharmTech ProductsPharma InsightsSponsored PodcastsSponsored VideosSponsored eBooksState of the ScienceWhitepapers

Subscribe

  • News
  • Publications
  • Multimedia
  • Conferences
  • Webcasts
  • Resources
  • Subscribe
  • Analytics
    • Bio/Pharmaceutical Analysis Techniques
    • Laboratory Equipment and Instruments
  • Data and Artificial Intelligence
  • Dosage Forms
    • Solid/Semi-Solid Dosage
    • Specialty Dosage Drugs
    • Parenterals and Injectables
    • Inhalation Drugs
  • Drug Development
    • Intellectual Property and Patents
    • Process and Scaling
    • APIs and Excipients
    • Ingredients
    • Formulation and Drug Delivery
  • Manufacturing
    • Aseptic/Sterile Processing
    • Equipment
    • Process and Automation
    • Manufacturing, Parenterals and Injectables
    • Manufacturing, Biosimilars and Biobetters
    • Manufacturing, Inhalation Drugs
    • Manufacturing, Solid and Semi-Solid Dosage Drugs
    • Manufacturing, Cell Therapies
    • Manufacturing, Biologic Drugs
    • Supply Chain
    • Manufacturing, Gene Therapies
    • Packaging and Distribution
  • Outsourcing
    • Contract Research Services
    • Contract Analytical Services
    • Contract Development Services
    • Regulatory Consulting
    • Logistics and Distribution
    • Contract Manufacturing Services
  • Quality Systems
    • Ask the Expert
    • Quality Assurance/Quality Control
    • Regulatory Oversight and Compliance
Spotlight -
Analytics|
Dosage Forms|
Drug Development|
Manufacturing|
Outsourcing|
Quality Systems
Advertisement

Jette Wypych

Advertisement

Jette Wypych is director, Attribute Sciences at Amgen.

Articles by Jette Wypych

Analytical Procedure Lifecycle Management: Current Status and Opportunities

ByMelissa Hanna-Brown,Joachim Ermer,Stephanie Katzenbach,Andy Rignall,Annick Gervais,Jörg Hoffmann,Jette Wypych,Kieran McLaughlin,Phil Borman,Oliver Grosche,Peter Hamilton,Thomas Uhlich,Christof Finkler,Katrin Liebelt
December 2nd 2018

Drawing on practical experience, the authors examine key questions and answers about various aspects relating to the enhanced approach for analytical procedure lifecycle management.

Advertisement

Latest Updated Articles

  • Analytical Procedure Lifecycle Management: Current Status and Opportunities
    Analytical Procedure Lifecycle Management: Current Status and Opportunities

    December 2nd 2018



Advertisement
Advertisement

Trending on Pharmaceutical Technology

1

Zumilokibart: Inside AbbVie's $10.9B Pipeline Bet

2

Why the First Generic Single-Dose Flu Antiviral Approval Matters

3

Germany Pharma Tariff Threat: What Manufacturers Need to Know

4

PharmTech Weekly Roundup—June 19, 2026

5

Why Pharma Dealmaking Slowed in Q1 2026 and What Is Coming Next

  • About Us
  • Advertise
  • Contact Us
  • Editorial Info
  • Editorial Advisory Board
  • Do Not Sell My Personal Information
  • Privacy Policy
  • Terms and Conditions
Contact Info

259 Prospect Plains Rd, Bldg H
Cranbury, NJ 08512

Brand Logo

© 2026 MJH Life Sciences®

All rights reserved.

Home
About Us
News
Contact Us